Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Tirofiban Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20249446

Company河南润弘制药股份有限公司

Registration Date

November 22, 2024

Drug Information

Generic Name

盐酸替罗非班氯化钠注射液

Dosage Form

注射剂

Strength

250ml：盐酸替罗非班（按C₂₂H₃₆N₂O₅S计）12.5mg与氯化钠2.25g

Drug Type

化学药品

Registration Date

November 22, 2024

Company Information

Applicant Company

Company Name河南润弘制药股份有限公司

Company Address

新郑市庆安路227号

Manufacturing Company

Company Name山东华鲁制药有限公司

Company Address

山东省聊城市茌平区振兴街道华鲁街1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸替罗非班氯化钠注射液 - NMPA 批准文号 | MedPath